These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells. Whitemarsh RC, Tepp WH, Johnson EA, Pellett S. PLoS One; 2014 Jan 03; 9(2):e90252. PubMed ID: 24587301 [Abstract] [Full Text] [Related]
3. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6. Moritz MS, Tepp WH, Bradshaw M, Johnson EA, Pellett S. mSphere; 2018 Oct 24; 3(5):. PubMed ID: 30355669 [Abstract] [Full Text] [Related]
4. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons. Kroken AR, Blum FC, Zuverink M, Barbieri JT. Infect Immun; 2017 Jan 24; 85(1):. PubMed ID: 27795365 [Abstract] [Full Text] [Related]
5. Botulinum neurotoxin type A subtype 2 confers greater safety than subtype 1 in a rat Parkinson's disease model. Itakura M, Kohda T, Kubo T, Semi Y, Nishiyama K, Azuma YT, Nakajima H, Kozaki S, Takeuchi T. J Vet Med Sci; 2014 Aug 24; 76(8):1189-93. PubMed ID: 24849052 [Abstract] [Full Text] [Related]
6. Uptake of botulinum neurotoxin into cultured neurons. Keller JE, Cai F, Neale EA. Biochemistry; 2004 Jan 20; 43(2):526-32. PubMed ID: 14717608 [Abstract] [Full Text] [Related]
7. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells. Kohda T, Tsukamoto K, Torii Y, Kozaki S, Mukamoto M. Microbiol Immunol; 2020 Jul 20; 64(7):502-511. PubMed ID: 32301520 [Abstract] [Full Text] [Related]
8. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype. Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG. PLoS One; 2015 Jul 20; 10(2):e0116381. PubMed ID: 25658638 [Abstract] [Full Text] [Related]
9. Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors. Ruthel G, Burnett JC, Nuss JE, Wanner LM, Tressler LE, Torres-Melendez E, Sandwick SJ, Retterer CJ, Bavari S. Toxins (Basel); 2011 Mar 20; 3(3):207-17. PubMed ID: 22069707 [Abstract] [Full Text] [Related]
10. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes. Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA. mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398 [Abstract] [Full Text] [Related]
11. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling. Pellett S, Tepp WH, Scherf JM, Johnson EA. PLoS One; 2015 Mar 27; 10(7):e0133737. PubMed ID: 26207366 [Abstract] [Full Text] [Related]
12. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro. Whitemarsh RC, Tepp WH, Bradshaw M, Lin G, Pier CL, Scherf JM, Johnson EA, Pellett S. Infect Immun; 2013 Oct 27; 81(10):3894-902. PubMed ID: 23918782 [Abstract] [Full Text] [Related]
13. Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative. Scherf JM, Hu XS, Tepp WH, Ichtchenko K, Johnson EA, Pellett S. PLoS One; 2014 Oct 27; 9(10):e111238. PubMed ID: 25337697 [Abstract] [Full Text] [Related]
14. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival. Williamson LC, Neale EA. J Neurosci Res; 1998 Jun 01; 52(5):569-83. PubMed ID: 9632313 [Abstract] [Full Text] [Related]
15. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT. J Biol Chem; 2012 Nov 23; 287(48):40806-16. PubMed ID: 23027864 [Abstract] [Full Text] [Related]
16. Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a. Wang T, Martin S, Papadopulos A, Harper CB, Mavlyutov TA, Niranjan D, Glass NR, Cooper-White JJ, Sibarita JB, Choquet D, Davletov B, Meunier FA. J Neurosci; 2015 Apr 15; 35(15):6179-94. PubMed ID: 25878289 [Abstract] [Full Text] [Related]
17. Enhancing toxin-based vaccines against botulism. Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT. Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477 [Abstract] [Full Text] [Related]
18. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons. Pellett S, Tepp WH, Johnson EA, Sesardic D. J Pharmacol Toxicol Methods; 2017 Nov 01; 88(Pt 1):1-6. PubMed ID: 28465161 [Abstract] [Full Text] [Related]
19. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model. Zhang P, Ray R, Singh BR, Ray P. Toxicon; 2013 Dec 15; 76():37-43. PubMed ID: 24047963 [Abstract] [Full Text] [Related]
20. Substrate-based inhibitors exhibiting excellent protective and therapeutic effects against Botulinum Neurotoxin A intoxication. Guo J, Wang J, Gao S, Ji B, Waichi Chan E, Chen S. Sci Rep; 2015 Nov 20; 5():16981. PubMed ID: 26584873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]